Kelly Purcell
Family Medicine · Greenville, SCNPI 1265473375
Payments from drug & device makers
Across 109 payments — averaging $16.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$366
- Novo Nordisk$238
- AbbVie$192
- Boehringer Ingelheim$179
- Amarin Pharma, Inc.$124
- Lilly USA, LLC$123
- plus $599 from 17 others
What the payments were for
- Food & beverage$1,820100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 14 | $366 |
| Novo Nordisk | 22 | $238 |
| AbbVie(2 entities) | 12 | $192 |
| Boehringer Ingelheim | 12 | $179 |
| Amarin Pharma, Inc. | 8 | $124 |
| Lilly USA, LLC | 8 | $123 |
| Incyte Corporation | 1 | $117 |
| Novartis | 5 | $71 |
| Pfizer | 5 | $64 |
| Merck | 4 | $56 |
| Amgen | 4 | $53 |
| Samsung HME America, Inc. | 1 | $50 |
| GSK | 2 | $38 |
| Exact Sciences | 2 | $31 |
| Bayer | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $14 |
| Gilead | 1 | $14 |
| Shire North American Group Inc | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
| Abbott | 1 | $12 |
| Esperion Therapeutics, Inc. | 1 | $12 |
| Sunovion Pharmaceuticals Inc. | 1 | $12 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,820 in reported general payments places this provider in the 70th percentile of 2,153 family medicine providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 129 | $186,469 |
| FarxigaDapagliflozin Propanediol | 89 | $85,539 |
| JanuviaSitagliptin Phosphate | 65 | $67,414 |
| JardianceEmpagliflozin | 55 | $64,848 |
| VraylarCariprazine Hcl | 19 | $26,528 |
| LinzessLinaclotide | 15 | $23,324 |
| MounjaroTirzepatide | 14 | $18,494 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 31 | $17,825 |
| MyrbetriqMirabegron | 21 | $15,072 |
| InvokanaCanagliflozin | 15 | $14,089 |
| TrulicityDulaglutide | 12 | $10,794 |
| TradjentaLinagliptin | 13 | $10,552 |
| VascepaIcosapent Ethyl | 14 | $10,219 |
| Dexlansoprazole DrDexlansoprazole | 14 | $3,948 |
| Fenofibrate | 127 | $2,860 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $238 | $186,469129 claims |
| AstraZenecaFarxiga | $366 | $85,53989 claims |
| Boehringer IngelheimJardiance, Tradjenta | $179 | $75,39968 claims |
| MerckJanuvia | $56 | $67,41465 claims |
| AbbVieVraylar, Linzess, Synthroid | $192 | $51,83650 claims |
| Lilly USA, LLCMounjaro, Trulicity | $123 | $29,28926 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,153 family medicine providers in South Carolina.
Other family medicine in Greenville
- James FranklinGreenville$3.5M
- Jeffrey HarrisGreenville$3.4M
- Christopher DavisGreenville$2.7M
- Harlicia FarleyGreenville$1.1M
- James WallaceGreenville$708K
- Eric Garcia-TorresGreenville$102K
- Cayce TangemanGoose Creek$8.4M
- Jeremy AckermannMoncks Corner$7.6M
- Kelly MoralesNorth Charleston$6.5M
- William ByarsGreer$4.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.